Predicted economic damage from a quick, simple Alzheimer's disease cure

Area of Science:

• Neurology
• Public Health
• Health Economics

Background:

• Alzheimer's disease (AD) affects millions, imposing significant economic burdens globally.
• Despite numerous drug trials, an effective AD therapeutic remains undiscovered.
• Pessimism regarding a cure has hindered economic contingency planning.

Purpose of the Study:

• To analyze the potential economic impacts of a hypothetical, rapid cure for Alzheimer's disease.
• To identify sectors within the healthcare industry that may face detrimental financial consequences.
• To inform contingency planning for economic transitions.

Main Methods:

• Economic modeling of healthcare expenditures and revenue shifts.
• Analysis of potential job losses and impacts on financial reserves.
• Projection of savings for government healthcare programs.

Main Results:

• A cure could lead to a $414 billion revenue loss across six healthcare sectors.
• Nursing homes and skilled nursing facilities face the largest revenue declines ($51B and $16B, respectively).
• An estimated 654,000 jobs could be lost, impacting Social Security and pension reserves.

Conclusions:

• While a cure presents economic challenges, particularly for specific healthcare facilities and employment, it offers significant financial benefits to government programs like Medicare and Medicaid.
• Proactive planning is crucial to mitigate negative economic repercussions for affected sectors and personnel.
• Identifying at-risk sectors allows for the development of transition strategies to manage the economic fallout of an Alzheimer's cure.